Indeed the GLP-1(7-36) NH2 receptor, a GPCR, is found to be expressed by a wide range of tissues and cells such as: , , and -cells (169), sinoatrial node myocytes, arterial smooth muscle cells of lungs and kidneys, megakaryocytes, macrophages, monocytes, lymphocytes, gastrointestinal tract mucosa [mainly Brunner's gland in the duodenum, but also in the parietal cells of the stomach, jejunum ileum and the nerve plexus around the small and large intestine (170, 171)], central nervous system [neocortex, cerebellum, thalamus, amygdala, area postrema, hypothalamus, hippocampus, nucleus tractus solitarius (158)], peripheral nervous system (myenteric plexus) and in the skin (172176)
The numbers in cells indicate the number of genes found and the entries in bracket are uniprot ids (for Annotated genes) and (GI ids for RPS-Blast results)
Your stomach requires massive amounts of water to liquify solid food and move it efficiently through the narrow lower digestive valves
These are systemic biomarkers and should not be presented as direct measurements of inflammation inside the brain
See the conversion chart for cross-pharmacy dose calculations
Summary of the Compounded Medication Warning (Mini-List) Compounded semaglutide and tirzepatide are not the same as FDA-approved formulations Salt forms such as semaglutide sodium and semaglutide acetate are not clinically validated Potency, purity, and dosing consistency cannot be guaranteed The FDA has issued multiple warnings regarding safety and legality Taylor Bariatric Institute prescribes only FDA-approved medications from legitimate pharmacies Summary Medical weight loss is most effective when treatment plans are built around safe, proven, FDA-approved medications that target the true physiologic and behavioral drivers of obesity